Viewing StudyNCT00006262



Ignite Creation Date: 2024-05-05 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006262
Status: TERMINATED
Last Update Posted: 2012-06-11
First Post: 2000-09-11

Brief Title: Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer
Sponsor: Northwestern University
Organization: Northwestern University

Organization Data

Organization: Northwestern University
Class: OTHER
Study ID: NCI 00G1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Northwestern University
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH